BioMarin Pharmaceutical, Inc. (BMRN)
65.88
+1.22
(+1.88%)
USD |
NASDAQ |
Aug 31, 13:40
BioMarin Pharmaceutical Free Cash Flow : 725.08M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 725.08M |
| March 31, 2026 | 759.12M |
| December 31, 2025 | 717.02M |
| September 30, 2025 | 825.79M |
| June 30, 2025 | 691.16M |
| March 31, 2025 | 620.18M |
| December 31, 2024 | 475.42M |
| September 30, 2024 | 300.88M |
| June 30, 2024 | 212.80M |
| March 31, 2024 | 163.21M |
| December 31, 2023 | 51.65M |
| September 30, 2023 | 31.29M |
| June 30, 2023 | 40.91M |
| March 31, 2023 | 21.77M |
| December 31, 2022 | 44.36M |
| September 30, 2022 | 40.76M |
| June 30, 2022 | -4.394M |
| March 31, 2022 | 23.95M |
| December 31, 2021 | 185.31M |
| September 30, 2021 | 165.24M |
| June 30, 2021 | 154.60M |
| March 31, 2021 | 92.32M |
| December 31, 2020 | -52.15M |
| September 30, 2020 | -2.405M |
| June 30, 2020 | -32.93M |
| Date | Value |
|---|---|
| March 31, 2020 | -84.15M |
| December 31, 2019 | -108.57M |
| September 30, 2019 | -97.77M |
| June 30, 2019 | -135.96M |
| March 31, 2019 | -135.36M |
| December 31, 2018 | -124.41M |
| September 30, 2018 | -156.98M |
| June 30, 2018 | -158.51M |
| March 31, 2018 | -131.12M |
| December 31, 2017 | -207.98M |
| September 30, 2017 | -234.48M |
| June 30, 2017 | -266.76M |
| March 31, 2017 | -309.09M |
| December 31, 2016 | -376.22M |
| September 30, 2016 | -496.44M |
| June 30, 2016 | -507.38M |
| March 31, 2016 | -484.36M |
| December 31, 2015 | -449.50M |
| September 30, 2015 | -333.48M |
| June 30, 2015 | -320.02M |
| March 31, 2015 | -323.80M |
| December 31, 2014 | -193.05M |
| September 30, 2014 | -178.04M |
| June 30, 2014 | -166.79M |
| March 31, 2014 | -131.95M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Incyte Corp. | 1.890B |
| Vertex Pharmaceuticals, Inc. | 3.796B |
| BridgeBio Pharma, Inc. | -437.79M |
| Ionis Pharmaceuticals, Inc. | -567.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 168.11M |
| Cash from Investing (Quarterly) | -5.102B |
| Cash from Financing (Quarterly) | 2.738B |
| Free Cash Flow Per Share (Quarterly) | 0.6883 |
| Free Cash Flow to Equity (Quarterly) | -2.638B |
| Free Cash Flow to Firm (Quarterly) | 180.02M |
| Free Cash Flow Yield | 5.67% |